Triteq have worked with Zilico Ltd, a spin-out company from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield, from the initial concept stage of Zedscan 1, a ground breaking cervical cancer diagnostic device. So we were delighted to hear thatZedScan Ihas obtained approval from Therapeutic Goods Administration (TGA) - the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. TGA approval for ZedScan means that is now listed on the register of medical devices and can be sold to the Australian Market. TGA approval is also accepted by other countries including Singapore and is viewed positively by regulatory authorities where there is a Mutual Recognition Agreement in place such as New Zealand.
Read the rest of entry »